Jennison Associates LLC bought a new position in shares of Embecta Corp. (NASDAQ:EMBC – Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 42,152 shares of the company’s stock, valued at approximately $594,000. Jennison Associates LLC owned 0.07% of Embecta at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in EMBC. Copeland Capital Management LLC bought a new position in Embecta during the 3rd quarter worth $43,000. Iat Reinsurance Co. LTD. bought a new position in Embecta during the 2nd quarter worth $50,000. CWM LLC increased its stake in Embecta by 773.8% during the 2nd quarter. CWM LLC now owns 9,079 shares of the company’s stock worth $113,000 after acquiring an additional 8,040 shares during the period. Canada Pension Plan Investment Board bought a new position in Embecta during the 2nd quarter worth $140,000. Finally, Cardinal Capital Management increased its stake in shares of Embecta by 16.8% in the 2nd quarter. Cardinal Capital Management now owns 11,753 shares of the company’s stock valued at $147,000 after purchasing an additional 1,691 shares during the last quarter. Institutional investors own 93.83% of the company’s stock.
Embecta Stock Down 1.3 %
Shares of EMBC stock opened at $13.82 on Monday. The business has a fifty day simple moving average of $14.38 and a 200 day simple moving average of $14.01. The company has a market cap of $797.44 million, a P/E ratio of 11.52 and a beta of 0.97. Embecta Corp. has a twelve month low of $9.93 and a twelve month high of $19.79.
Embecta Company Profile
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
Featured Stories
- Five stocks we like better than Embecta
- Short Selling: How to Short a Stock
- Disney’s Magic Strategy: Reinventing the House of Mouse
- What Investors Need to Know to Beat the Market
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- ESG Stocks, What Investors Should Know
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Want to see what other hedge funds are holding EMBC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Embecta Corp. (NASDAQ:EMBC – Free Report).
Receive News & Ratings for Embecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embecta and related companies with MarketBeat.com's FREE daily email newsletter.
